The Poisons Standard (the SUSMP)

2 March 2015

The Poisons Standard is a Legislative Instrument for the purposes of the Legislative Instruments Act 2003. The Poisons Standard consists of decisions regarding the classification of medicines and poisons into Schedules for inclusion in the relevant legislation of the States and Territories. The Poisons Standard also includes model provisions about containers and labels, a list of products recommended to be exempt from these provisions, and recommendations about other controls on drugs and poisons.

The Poisons Standard has been presented with a view to promoting uniform scheduling of substances and uniform labelling and packaging requirements throughout Australia.

The Poisons Standard is the legal title of the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP).

The SUSMP

The Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP):

  • is a record of decisions regarding the classification of medicines and chemicals into Schedules for inclusion in relevant legislation of the states and territories;
  • includes model provisions about containers and labels, and recommendations about other controls on medicines and chemicals; and
  • is registered on the Federal Register of Legislative Instruments as the Poisons Standard.

Recent changes

SUSMP No.6 is the current edition. It incorporates a number of new changes to the Poisons Standard 2014. These amendments principally involve changes to existing entries, and the inclusion of a small number of specified substances in the Poisons Standard for the first time.

A number of these changes were made following the provision of advice from the March 2014 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS). Public comment was invited on those matters referred to the ACMS, the ACCS and a joint meeting of the ACMS and the ACCS, which related to proposals to amend the Poisons Standard in relation to the following substances:

  • Calcium hydroxylapatitie - the invitation to comment in relation to this substance was advertised on the TGA website from 29 May 2014, and closed on 26 June 2014;
  • Macitentan - the invitation to comment in relation to this substance was advertised on the TGA website from 29 May 2014, and closed on 26 June 2014;
  • Polycaprolactone - the invitation to comment in relation to this substance was advertised on the TGA website from 29 May 2014, and closed on 26 June 2014;
  • Riociguat - the invitation to comment in relation to this substance was advertised on the TGA website from 29 May 2014, and closed on 26 June 2014;
  • Suvorexant - the invitation to comment in relation to this substance was advertised on the TGA website from 29 May 2014, and closed on 26 June 2014;
  • Triethanolamine - the invitation to comment in relation to this substance was advertised on the TGA website from 29 May 2014, and closed on 26 June 2014;
  • Metofluthrin - the invitation to comment in relation to this substance was advertised on the TGA website from 29 May 2014, and closed on 26 June 2014;
  • Fosthiazate - the invitation to comment in relation to this substance was advertised on the TGA website from 29 May 2014, and closed on 26 June 2014;
  • Phenylenediamines - the invitation to comment in relation to this substance was advertised on the TGA website from 29 May 2014, and closed on 26 June 2014;
  • 1,2-Benzenediamine - the invitation to comment in relation to this substance was advertised on the TGA website from 29 May 2014, and closed on 26 June 2014;
  • 1,3-Benzenediamine - the invitation to comment in relation to this substance was advertised on the TGA website from 29 May 2014, and closed on 26 June 2014;
  • 2,4-Toluenediamine- the invitation to comment in relation to this substance was advertised on the TGA website from 29 May 2014, and closed on 26 June 2014; and
  • Cocoyl Glycinate - the invitation to comment in relation to this substance was advertised on the TGA website from 13 June 2013, and closed on 11 July 2013.

The delegates' final decisions in relation to these matters were published on the TGA website on 8 November 2013, 23 and 28 October 2014, and 17 and 24 December 2014.

Other amendments set out in this instrument added a number of new substances to the Poisons Standard for the first time, including benamustine, bosutinib, brentuximab, carglumic acid, elosulfase alfa, fluralaner, macitentan, oclacitinib, pyriofenone, riociguat, simoctocog alfa and suvorexant.

The implementation date for the above decisions was 1 February 2015.

The SUSMP No.6 also includes a small number of editorial amendments in accordance with the recommendations of the Australian Health Ministers’ Advisory Council (AHMAC) Out of Session item 645 titled Uniform controls on Poisons on 7 August 2014. These amendments are:

  • renaming Part 2 from 'Labels and Containers' to 'Controls on Medicines and Poisons';
  • incorporating Appendix I ('Uniform Paint Standard') into Part 2;
  • renaming Appendix C as Schedule 10; and
  • restructuring Parts 2 and 3 into sections.

Electronic version of the SUSMP

The SUSMP is available in electronic form, free of charge, on the ComLaw website at the Federal Register of Legislative Instruments (FRLI). The FRLI is a repository and authoritative source of Commonwealth legislative instruments, explanatory statements and compilations of legislative instruments in electronic form.

Please note that on FRLI the SUSMP goes by its legal title, the Poisons Standard. Additionally, rather than referring to the edition number, the publication will be named according to the year of publication (i.e. the year it is published on FRLI). For example, SUSMP No.6 is known as Poisons Standard 2015 on FRLI.

Please note that the SUSMP No.6 and all future editions of the Poisons Standard will only be available online.